Since 2001, Tammy has built extensive experience in value communication, access strategy, and HEOR evidence generation, working with global, European, US, and country-level teams.
She is a collaborative professional, adept at balancing perspectives from clinical, commercial, and economic disciplines, and is a passionate advocate for precise, strategic, evidence-based writing.
Tammy has conceptualised and led a wide range of projects across diverse pharma and biotech clients and therapy areas. She has particular expertise in rare disease access strategy/evidence planning, as well as significant experience in neurology and oncology. Her work includes developing value stories and strategies, dossiers, evidence generation and real-world studies, economic models, systematic reviews, HTA submissions, and facilitating training, workshops, advisory boards, and symposia.